Meribank Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	136.2	165.09	399.46	85.16	192.15	51.4
Short-Term Investments	-	-	-	122.7	94.1	45.9
Cash & Short-Term Investments	136.2	165.09	399.46	207.86	286.25	97.3
Cash Growth	-17.84%	-58.67%	92.18%	-27.39%	194.21%	-39.10%
Accounts Receivable	166.19	158.22	128.63	146.97	147.53	136.06
Other Receivables	6.19	8.82	6.5	5.47	1.63	0.14
Receivables	172.38	167.04	135.13	152.44	149.17	136.2
Inventory	9.67	11.24	6.91	8.45	3.6	2.94
Prepaid Expenses	37.32	49.6	28.61	24.13	19.87	19.03
Other Current Assets	0.37	0.34	0.09	0.02	0.11	-
Total Current Assets	355.94	393.31	570.19	392.9	458.99	255.46
Property, Plant & Equipment	461.4	479.46	162.06	178.19	190.76	210.04
Long-Term Investments	57.53	59.57	59.56	25.22	44.45	18.89
Goodwill	282.18	282.18	2.87	-	-	-
Other Intangible Assets	565.21	584.09	31.69	10.22	1.09	1.92
Long-Term Deferred Tax Assets	4.05	3.8	2.48	-	-	-
Other Long-Term Assets	1,105	879.54	233.17	239.8	252.03	243.65
Total Assets	2,831	2,682	1,062	846.33	947.32	729.97
Accounts Payable	7.25	13.08	12.32	7.6	4.75	4.99
Accrued Expenses	56.89	53.9	50.63	45.84	44.57	44.66
Current Portion of Long-Term Debt	7.39	7.32	-	-	-	-
Current Portion of Leases	107.87	70.85	19.23	21.58	18.25	19.99
Current Unearned Revenue	25.85	27.33	17.56	14.76	12.97	12.3
Other Current Liabilities	20.22	59.76	27.17	19.28	15.34	16.96
Total Current Liabilities	225.47	232.23	126.91	109.07	95.87	98.9
Long-Term Debt	159.16	162.88	-	-	-	-
Long-Term Leases	862.24	701.79	14.81	24.25	34.73	49.93
Long-Term Unearned Revenue	267.39	258.41	245.7	236.52	228.14	195.56
Long-Term Deferred Tax Liabilities	96.67	99.83	1.38	0.65	-	-
Other Long-Term Liabilities	9.36	9.42	2.02	2.05	2.53	2.95
Total Liabilities	1,620	1,465	390.81	372.53	361.27	347.34
Common Stock	879.76	879.76	709.76	627.76	627.76	526.71
Additional Paid-In Capital	717.31	710.82	233.2	203.24	203.74	2.88
Retained Earnings	-392.29	-373.23	-272.2	-350.09	-247.58	-148.39
Comprehensive Income & Other	-5.25	-11.62	-9.04	-9.71	2.12	1.43
Total Common Equity	1,200	1,206	661.73	471.2	586.05	382.64
Minority Interest	11.37	11.65	9.46	2.59	-	-
Shareholders' Equity	1,211	1,217	671.2	473.79	586.05	382.64
Total Liabilities & Equity	2,831	2,682	1,062	846.33	947.32	729.97
Total Debt	1,137	942.84	34.04	45.83	52.97	69.92
Net Cash (Debt)	-1,000	-777.75	365.42	162.03	233.28	27.38
Net Cash Growth	-	-	125.53%	-30.54%	752.06%	-79.34%
Net Cash Per Share	-11.37	-9.78	5.81	2.58	3.87	0.52
Filing Date Shares Outstanding	87.98	87.98	70.98	62.78	62.78	52.67
Total Common Shares Outstanding	87.98	87.98	70.98	62.78	62.78	52.67
Working Capital	130.47	161.08	443.27	283.83	363.12	156.56
Book Value Per Share	13.63	13.71	9.32	7.51	9.34	7.26
Tangible Book Value	352.14	339.46	627.17	460.98	584.96	380.72
Tangible Book Value Per Share	4.00	3.86	8.84	7.34	9.32	7.23
Land	214.7	214.7	41.08	41.08	41.08	41.08
Buildings	107.62	107.62	53.84	53.23	52.95	52.95
Machinery	101.02	96.57	76.56	61.45	62.83	61.07

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.